Taiwan FDA registration 805bcb7b0df3317056708e6b58f7b84a
"Daishoulin" human growth hormone radioimmunoassay reagent
TW: “代首林”人體生長激素放射免疫分析試劑
Taiwan·Risk Class 2·DIASORIN INC.;;DIASORIN S.P.A.·Registered Mar 31, 2006 – Mar 31, 2011CancelledRegistration details
- Analysis ID
- 805bcb7b0df3317056708e6b58f7b84a
- Customs Code
- DHAS0601628303
Company information
- Manufacturer
- DIASORIN INC.;;DIASORIN S.P.A.
- Manufacturer Country
- Italy;;United States
- Authorized Representative
- TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
- Intended Use
- Quantitative measurement of growth hormone (hGH) in human serum or blood pump.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1370 Human Growth Hormone Testing System
- Import Information
- Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
Dates and status
- Registration Date
- Mar 31, 2006
- Expiry Date
- Mar 31, 2011
- Cancellation Date
- Nov 27, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Daishoulin" human growth hormone radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 805bcb7b0df3317056708e6b58f7b84a and manufactured by DIASORIN INC.;;DIASORIN S.P.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices